This rapidly growing Genetic Monitoring Facility is used by 20 peer-reviewed, funded investigators from 8 Research Programs using animal models in 36 research protocols. In 2003, 97.7% of the research projects utilizing this Facility were supported by peer-reviewed funding. Good genetic monitoring has become critical to the laboratory animal needs of the Fox Chase Cancer Center (FCCC) research community, as animals used in today's biomedical research must not only be free of disease, but also be well defined in terms of their genetic makeup. At present, we monitor 11 different loci located on 9 different chromosomes. We are currently maintaining 170 lines of mice for FCCC investigators and continue to add an average of one new transgenic line per month. During the past year, the Facility has performed 5,856 genetic profile tests, a 225% increase from the 1,800 performed in 1999. Service hours for genetic monitoring services have also increased dramatically, up 140% from 342 in 1999 to 821 in 2003. The daily operation of breed ng colonies is handled by personnel trained and experienced in genetic management and record-keeping. Regular review, advice and guidance is provided by Bruce Elder, Ph.D., a consultant geneticist added in March 2004 who makes quarterly visits and reviews reports and activities in all rodent colonies, and all of the breeding, production and genetic monitoring records have been computerized. These computerized records enable us to closely monitor breeding performance, pedigree lines, and utilization of the various inbred lines and strains. The ability to monitor the genome, and maintain the breeding colonies, of unique immunodeficient and transgenic mice enhances the interaction among Members of the Immunobiology Program as well as Members of the Cellular and Developmental Biology (Burch), Mintz (Tumor Cell Biology), Human Genetics (Testa, Program Leader), Developmental Therapeutics (Kruh, Smith, Weiner, Program Leader), and Cancer Prevention and Control (Clapper) Programs. Genetic Monitoring services have become a critical part of research with animals, and the need for services is expected to continue to increase 18% per year in the future. We propose adding one FTE to support this increase in Facility activities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006927-46
Application #
7651452
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
46
Fiscal Year
2008
Total Cost
$176,653
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
073724262
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Reese, Jennifer Barsky; Smith, Katherine Clegg; Handorf, Elizabeth et al. (2018) A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors. J Psychosoc Oncol :1-22
Shaikh, Talha; Handorf, Elizabeth A; Meyer, Joshua E et al. (2018) Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. JAMA Oncol 4:e173580
Roy, Anuradha (2018) Early Probe and Drug Discovery in Academia: A Minireview. High Throughput 7:
Auerbach, M V; Heckman, C J; Darlow, S (2018) To protect or not to protect: examining reasons for sun protection among young women at risk for skin cancer. J Behav Med 41:528-536
Diefenbach, Michael A; Benedict, Catherine; Miller, Suzanne M et al. (2018) Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT. Transl Behav Med 8:876-886
Ross, Kayleigh C; Chin, Kevin F; Kim, Daehwan et al. (2018) Methotrexate sensitizes drug-resistant metastatic melanoma cells to BRAF V600E inhibitors dabrafenib and encorafenib. Oncotarget 9:13324-13336
Shafi, Ayesha A; Schiewer, Matthew J; de Leeuw, Renée et al. (2018) Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol 1:325-337
Mazor, Anna M; Mateo, Alina M; Demora, Lyudmila et al. (2018) Breast conservation versus mastectomy in patients with T3 breast cancers (>?5 cm): an analysis of 37,268 patients from the National Cancer Database. Breast Cancer Res Treat :
Ingram, Justin P; Tursi, Sarah; Zhang, Ting et al. (2018) A Nonpyroptotic IFN-?-Triggered Cell Death Mechanism in Nonphagocytic Cells Promotes Salmonella Clearance In Vivo. J Immunol 200:3626-3634
Chang, Wen-Chi L; Jackson, Christina; Riel, Stacy et al. (2018) Differential preventive activity of sulindac and atorvastatin in Apc+/Min-FCCCmice with or without colorectal adenomas. Gut 67:1290-1298

Showing the most recent 10 out of 1280 publications